Inactive Instrument

Marrone Bio Innovations, Inc.

Equities

MBII

US57165B1061

Agricultural Chemicals

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from S&P TMI Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from S&P Global BMI Index CI
Bioceres Crop Solutions Completes Marrone Bio Innovations Deal MT
Marrone Bio Innovations, Inc. Announces Kevin Helash Will Be Step Down as Chief Executive Officer CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from NASDAQ Composite Index CI
Bioceres Crop Solutions Corp. completed the acquisition of Marrone Bio Innovations, Inc. from Ardsley Advisory Partners LP, Ospraie Ag Science LLC and others. CI
Marrone Bio Innovations Shareholders Approve Merger Agreement With Bioceres Crop Solutions MT
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 2500 Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 2500 Growth Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell Small Cap Completeness Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 3000 Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 3000E Growth Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 3000E Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell Small Cap Comp Growth Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 2000 Growth Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 2000 Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 3000 Growth Index CI
Marrone Bio Innovations, Inc.(NasdaqCM:MBII) dropped from Russell 2000 Dynamic Index CI
Transcript : Marrone Bio Innovations, Inc., Q1 2022 Earnings Call, May 11, 2022
Earnings Flash (MBII) MARRONE BIO INNOVATIONS Posts Q1 Revenue $11.1M, vs. Street Est of $12.8M MT
Marrone Bio Innovations, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Earnings Flash (MBII) MARRONE BIO INNOVATIONS Posts Q1 Loss $-0.04, vs. Street Est of $-0.02 MT
Marrone Bio Innovations, Inc. Provides Revenue Guidance for the First Half of 2022 CI
Marrone Bio Innovations, Inc. Auditor Raises 'Going Concern' Doubt CI
Transcript : Marrone Bio Innovations, Inc., Q4 2021 Earnings Call, Mar 28, 2022
Chart Marrone Bio Innovations, Inc.
More charts
Marrone Bio Innovations, Inc. is an agricultural company that supports farming practices through the discovery, development, and sale of biological products for crop protection, crop health and crop nutrition. The Company offers 18 products that include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate, Zelto, and others. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. The Company's end markets are row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits; trees, nuts and vines, such as almonds and grapes; and greenhouse production, such as ornamentals and medicinal plants.
More about the company
  1. Stock
  2. Equities
  3. Stock Marrone Bio Innovations, Inc. - Nasdaq
  4. News Marrone Bio Innovations, Inc.
  5. Marrone Bio Innovations : Q1 Loss Narrows as Revenue Increases